FDA Requests Entereg Failed European Study Data, Adolor Says
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA requests Entereg failed European study data, Adolor reports. Alvimopan failed to show statistical significance for the primary endpoint in partner GlaxoSmithKline’s Phase III study. The pending NDA for the postoperative ileus therapy is based on three studies with mixed results